Sage Therapeutics Inc (SAGE)

5.15 +0.30 (+6.19%) USD  |  NASDAQ  |  Nov 22, 16:00
5.15 0.00 (0.00%) After-Hours: 20:00
More

Sage Therapeutics Research and Development Expense (Quarterly): 54.58M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2024 54.58M
June 30, 2024 62.56M
March 31, 2024 71.73M
December 31, 2023 64.33M
September 30, 2023 101.92M
June 30, 2023 97.16M
March 31, 2023 92.83M
December 31, 2022 89.30M
September 30, 2022 81.55M
June 30, 2022 77.30M
March 31, 2022 78.02M
December 31, 2021 75.44M
September 30, 2021 83.50M
June 30, 2021 66.17M
March 31, 2021 58.06M
December 31, 2020 81.71M
September 30, 2020 74.08M
June 30, 2020 73.32M
March 31, 2020 63.61M
December 31, 2019 91.25M
September 30, 2019 102.11M
June 30, 2019 89.06M
March 31, 2019 86.40M
December 31, 2018 88.80M
Date Value
September 30, 2018 75.05M
June 30, 2018 68.98M
March 31, 2018 49.27M
December 31, 2017 50.89M
September 30, 2017 58.29M
June 30, 2017 55.90M
March 31, 2017 45.20M
December 31, 2016 42.00M
September 30, 2016 29.08M
June 30, 2016 26.10M
March 31, 2016 23.58M
December 31, 2015 20.38M
September 30, 2015 17.48M
June 30, 2015 18.60M
March 31, 2015 12.90M
December 31, 2014 8.945M
September 30, 2014 6.601M
June 30, 2014 4.381M
March 31, 2014 4.173M
December 31, 2013 4.512M
September 30, 2013 3.408M
June 30, 2013 3.854M
March 31, 2013 2.583M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

54.58M
Minimum
Sep 2024
101.92M
Maximum
Sep 2023
76.92M
Average
76.37M
Median

Research and Development Expense (Quarterly) Benchmarks

Outset Medical Inc 8.139M
Biogen Inc 542.70M
Johnson & Johnson 4.952B
Lifecore Biomedical Inc 2.186M
Organon & Co 111.00M